Urologic nurse discusses the importance of medical conferences for APPs

Feature
Video

“We can all learn and collaborate from each other, that way we can continue to provide really great care for our patients,” says Mary W. Dunn, MSN, NP-C, OCN, RN.

In this interview, Mary W. Dunn, MSN, NP-C, OCN, RN, discusses why medical conferences such as the American Urologic Association (AUA) Annual Meeting are important for advanced practice providers (APPs). Dunn is a urologic nurse practitioner at the University of North Carolina in Chapel Hill.

Video Transcript:

I think it's really important for APPs in particular to continue to come to conferences, like the AUA. I think the AUA has done a really nice job over the years in including APPs giving talks, running sessions, we have a whole session Saturday and Sunday for APPs because there's a lot of us now, and we are part of the care team–integral parts of the care team. And I think the urology community has really done a nice job of embracing that. I think the more that APPs are involved in things like this, and continuing their own education, because everyone practices differently. I'm in academic medicine, whereas a community practice APP might be doing things a little bit differently. We can all learn and collaborate from each other, that way we can continue to provide really great care for our patients.

This transcription has been edited for clarity.

Recent Videos
Alexander Pastuszak, MD, PhD: Is hormone therapy safe after prostate cancer radiotherapy?
Refining prostate cancer therapy strategy to address RAPTOR findings
Considering patient-reported outcomes in kidney cancer care, with Nicholas Zaorsky, MD, PhD
Soumyajit Roy, MS, MBBS: The effect of prostate cancer patient history in RAPTOR
 Nicholas Zaorsky, MD, MS: Protecting kidney function after local renal cell carcinoma therapy
Daniel Carson, MD, MS, answers a question during a Zoom video interview
Nicholas van AS, MD, MBBCH: The case for SBRT as a standard of care for localized prostate cancer
Pierre Blanchard, MD, PhD: What can hydrogel space provide to optimal prostate cancer care?
Savita Dandapani, MD, PhD: Findings from the phase 2 SHARP trial
Benjamin Pockros, MD, MBA, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.